BCMU
WST icon

BlueCrest Capital Management (UK)’s West Pharmaceutical WST Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-12,000
Closed -$589K – 613
2013
Q4 		$589K Buy
+12,000
New +$562K 0.05% 276

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

BlueCrest Capital Management (UK)'s WST Position: Q1 2014 in Review

BlueCrest Capital Management (UK) sold out of West Pharmaceutical (WST) in Q1 2014, closing a stake of 12,000 shares — an estimated $589K sold.

BlueCrest Capital Management (UK) first reported a position in WST in Q4 2013 and held it in 1 quarter. The position peaked at $589K in Q4 2013. 226 funds tracked by Wall St. Rank hold WST as of Q1 2014.

  • BlueCrest Capital Management (UK) reported no remaining West Pharmaceutical position as of Q1 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 12,000 West Pharmaceutical shares in Q1 2014, an estimated $589K.
  • BlueCrest Capital Management (UK) first reported a position in West Pharmaceutical in Q4 2013 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s West Pharmaceutical position peaked at $589K in Q4 2013.
  • 226 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q1 2014, filed 15 May 2014.